BioCentury | Jan 15, 2021
Management Tracks
Frates joins ALS company Amylyx; plus Artios, Valneva, Viravaxx
After two decades at Alkermes plc (NASDAQ:ALKS), James Frates will join neurodegenerative diseases company Amylyx Pharmaceuticals Inc. as CFO on Jan. 25. Frates said he felt a “calling” to do more to combat amyotrophic lateral sclerosis after his cousin...